Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Yasho IndustriesQ1 FY27Chemicals & Petrochemicals
Home/Stocks/Yasho Industries/Q1 FY27

Yasho Industries Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹4,216P/E: 101.4Market Cap: ₹5.3K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 1

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 1
  • →Yasho Industries targets 30%-40% annual revenue growth over the next few years (Page 4).
  • →Growth is primarily driven by export markets, which currently contribute ~69% of revenue, expected to stabilize around 70%-75% export share (Pages 7, 18-19).
  • →Utilization is expected to ramp up from 60%-65% currently to 75% in FY27, supporting volume growth (Pages 12, 18-19).
  • →New capacity at Pakhajan facility's Phase 1 to be operational from Q1 FY28, with revenue potential of Rs. 100 crores in FY28, not included in FY27 guidance (Pages 18-19).
  • →Product mix improvement and new specialty products contribute to growth and better margins (Pages 14-15).
  • →Focus on long-term customer contracts reduces volatility and supports stable margin and volume growth (Pages 13-14).
  • →Expansion into Asian and African markets is underway, expected to contribute to export growth (Pages 7, 18).

Margin guidance

Category 3
  • →Yasho Industries targets 30%-40% annual revenue growth over the next few years, driven mainly by export markets and new product commercialization.
  • →Margins are expected to be maintained at current levels (~24%) for FY27, supported by improved product mix, higher capacity utilization (~75% targeted), and better operating leverage.
  • →The company expects sustained EBITDA margins due to long-term supply contracts with marquee customers rather than spot pricing.
  • →New product lines launched over the last 18-24 months contribute about 30% of revenue and are expected to drive future growth.
  • →CAPEX of Rs. 250 crores over FY27 towards new manufacturing facilities aims to support scaling operations with expected 2.5x revenue potential on CAPEX.
  • →Improving net debt/EBITDA ratio (1.86x in Q1 FY27 vs. 3.75x prior) reflects stronger operating earnings and disciplined financial management.
  • →Overall, Yasho aims for sustainable profit growth supported by capacity expansion, product innovation, and global market penetration.

3 more insights locked — sign up free to unlock

Fundraise plans

  • →Yasho Industries Limited plans to raise approximately Rs. 100 crores through borrowings (debt) during FY27 to fund its expansion and capital expenditure.
  • →No mention of any current or planned equity fundraising was noted in the document.
  • →The company is increasing its FY27 capital expenditure plan from Rs. 125 crores to Rs. 250 crores primarily to construct two new production buildings at the Pakhajan facility.
  • →The financial leverage has improved, with net debt to EBITDA ratio reducing from 3.75x at FY26 end to 1.86x as of June 30, 2026, supported by better operating earnings and profitability.

Order book

- As of the latest call, Yasho Industries has customers lined up for approximately 60%-65% of the new capacity coming online (Pakhajan facility Phase 1). - For the remaining capacity (around 35%-40%), the company is actively searching for customers to fill the balance. - Out of the Rs. 250 crores total CAPEX, about 65% is already booked with customers. - The company has secured commitments from marquee customers, which support confidence in maintaining margins and growth. - Long-term supply agreements are in place and are described as "evergreen," indicating ongoing customer commitments without immediate expiry. - Additional customer offtake observed in recent quarters is expected to continue, suggesting a healthy order pipeline. - Export markets, notably USA, Europe, Middle East, and new Asian and African markets, contribute significantly to order growth. Overall, the order book is robust for over half of planned expansions, with active efforts underway to secure the remainder.

Capex plans

Yes
  • →Yasho Industries revised FY27 CAPEX guidance from Rs. 125 crores to Rs. 250 crores.
  • →The investment will be directed towards constructing two new production buildings at the Pakhajan facility.
  • →These buildings will manufacture several high-potential products developed through R&D efforts.
  • →The first phase (Rs. 100 crores) is expected to come online by Q1 FY28; the second phase (Rs. 150 crores) by Q4 FY28.
  • →The total revenue potential from this CAPEX is expected to be 2.5x the invested amount.
  • →About 65% of the Rs. 250 crores CAPEX is already booked with customers.
  • →The new capacity is anticipated to contribute incremental revenue starting FY28, with a target utilization of around 70%-75%.
  • →The company also has ongoing projects aligned with customers' needs to support sustained growth.

How does Yasho Industries rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Yasho Industries
Rev 1Mar 3
2Chemicals & Petrochemicals Company A
Rev 1Mar 2
3Chemicals & Petrochemicals Company B
Rev 2Mar 1
4Chemicals & Petrochemicals Company C
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

How does Yasho Industries rank in Chemicals & Petrochemicals?

Compare Yasho Industries against every Chemicals & Petrochemicals company (Q1 FY27) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Yasho Industries

Other quarters — Yasho Industries

Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24

Chemicals & Petrochemicals peers

Aarti Industries · Q1 FY27BASF India · Q4 FY26Deepak Fertilis. · Q1 FY27Deepak Nitrite · Q1 FY27Himadri Special · Q1 FY27
Yasho Industries full stock analysisChemicals & Petrochemicals sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Yasho Industries's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q3 FY26 earnings call analysis →
  • Q3 FY25 earnings call analysis →
  • Q2 FY26 earnings call analysis →

Others in Chemicals & Petrochemicals this season

  • Fineotex Chemical Ltd (Q1 FY27)

    INR 1,000 crores in FY'26. Key concall takeaways from Fineotex Chemical Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Tanfac Inds. (Q1 FY27)

    Around 80% to 85% of the solar grade DHF plant capacity is contracted. Key concall takeaways from Tanfac Inds.'s Q1 FY27 earnings call — and how it ranks…

  • Epigral (Q1 FY27)

    Profit after tax (PAT) grew 25% in Q1 FY27 compared to Q1 FY26, reflecting resilience despite a challenging environment. Key concall takeaways from Epigral's…

  • S H Kelkar & Company Ltd (Q1 FY27)

    15 crore). Key concall takeaways from S H Kelkar & Company Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF